newsfilter
← Latest News
Business Wire·

Axcella Therapeutics Announces Upcoming Presentations at AASLD's The Liver Meeting® 2021

Axcella Therapeutics (NASDAQ:AXLA), a clinical-stage biotechnology company pioneering a new approach to treat complex diseases using multi-targeted endogenous metabolic modulator (EMM) compositions, today announced two upcoming poster presentations at T